Veradermics, Inc 13D

Montanova Capital and affiliates hold about 8.8% of Veradermics after recent sales and warrant exercises, with no explicit activist intentions disclosed in this amendment.

Montanova Capital, LLC, together with Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd., and control person Aaron Cowen, report beneficial ownership of 3,718,970 shares of Veradermics, Incorporated common stock, representing approximately 8.8% of the outstanding shares, following open‑market sales on August 19, 2026 and subsequent exercises of pre‑funded warrants on August 20, 2026; the amendment updates ownership structure and recent trading activity but does not state any new activist plans or intentions beyond investment purposes.

Filing Facts

CIK

1827635

Ticker

MANE

Form

13D

Source Type

fda

Accession

0000899140-26-000948

Alert Tier

6